• 통합자연과학논문집
• /
• 제7권4호
• /
• pp.253-259
• /
• 2014

Protein kinase C theta (PKC-${\theta}$) is a serine/threonine specific protein kinase. It is largely expressed in the T-cells and CD28 signaling. PKC-${\theta}$ phosphorylates diverse proteins that are involved in the various cellular signaling pathways. Activated PKC-${\theta}$ in turn activates other transcription factors that control the proliferation and differentiation of T- cells. PKC-${\theta}$ is considered to be an interesting therapeutic target due to its crucial role in the proliferation, differentiation and survival of T-cells. In the present study, we have performed ligand-based CoMFA study on a series of pyridylpyrazolopyridine derivatives as PKC-${\theta}$ inhibitors. An acceptable CoMFA model ($q^2$=0.544; ONC=4; $r^2$=0.876) was developed and validated by Bootsrapping and progressive sampling. The CoMFA contour map suggested the regions to increase the activity. Bulky substitutions in R2 position of the piperizine ring could increase the activity. Similarly positive, small substitution in the R1 position of the Pyridine ring could considerably increase the activity. Our work could assist in designing more potent PKC-${\theta}$ inhibitors of pyridylpyrazolopyridine derivatives.

• 통합자연과학논문집
• /
• 제13권4호
• /
• pp.170-180
• /
• 2020

Abnormal regulation, hyperphosphorylation, and aggregation of the tau protein are the hallmark of several types of dementia, including Alzheimer's Disease. Increased activity of Glycogen Synthase Kinase-3β (GSK-3β) in the Central Nervous System (CNS), increased the tau hyperphosphorylation and caused the neurofibrillary tangles (NFTs) formation in the brain cells. Over the last two decades, numerous adenosine triphosphate (ATP) competitive inhibitors have been discovered that show inhibitory activity against GSK-3β. But these compounds exhibited off-target effects which motivated researchers to find new GSK-3β inhibitors. In the present study, we have collected the dataset of 31 C-Glycosylflavones derivatives that showed inhibitory activity against GSK-3β. Among the dataset, the most active compound was docked with the GSK-3β and molecular dynamics (MD) simulation was performed for 50 ns. Based on the 50 ns MD pose of the most active compound, the other dataset compounds were sketched, minimized, and aligned. The 3D-QSAR based Comparative Molecular Field Analysis (CoMFA) model was developed, which showed a reasonable value of q2=0.664 and r2=0.920. The contour maps generated based on the CoMFA model elaborated on the favorable substitutions at the R2 position. This study could assist in the future development of new GSK-3β inhibitors.

• 통합자연과학논문집
• /
• 제15권4호
• /
• pp.179-186
• /
• 2022

The c-Jun N-terminal kinase (JNK3) play major role in neurodegenerative diseases like Alzheimer's disease, Parkinson's disease, cerebral ischemia and other Central Nervous System disorders. Since JNK3 is primarily stated in the brain and stimulated by stress-stimuli, this situation is conceivable that inhibiting JNK3 could be a possible treatment for the mechanisms underlying neurodegenerative diseases. In this study drugs from Zinc15 database were screened to identify the JNK3 inhibitors by Molecular docking and Density functional theory approach. Molecular docking was done by Autodock vina and the ligands were selected based on the binding affinity. Our results identified top ten novel ligands as potential inhibitors against JNK3. Molecular docking revealed that Venetoclax, Fosaprepitant and Avapritinib exhibited better binding affinity and interacting with proposed binding site residues of JNK3. Density functional theory was used to compute the values for energy gap, lowest unoccupied molecular orbital (LUMO), and highest occupied molecular orbital (HOMO). The results of Density functional theory study showed that Venetoclax, Fosaprepitant and Avapritinib serves as a lead compound for the development of JNK3 small molecule inhibitors.

• 한국응용약물학회:학술대회논문집
• /
• 한국응용약물학회 1998년도 Proceedings of UNESCO-internetwork Cooperative Regional Seminar and Workshop on Bioassay Guided Isolation of Bioactive Substances from Natural Products and Microbial Products
• /
• pp.184-184
• /
• 1998

Aldose reductase(AR), a rate-limiting enzyme in the polyol pathway, has been demonstrated to cause the intracellular accumulation of sorbitol or galactitol and hence to play key roles not only in the cataract formation in the lens but also in the pathogenesis of diabetic complications such as neuropathy, retinopathy and nephropathy, etc. In a series of investigations to evaluate potential AR inhibitors from medicinal plants, we have shown that some hot water extracts exhibited a significant inhibition of a significant inhibition of bovine lens AR in vitro. Among active plants, the roots of Angelica dahuria (Umbelliferae) were shown to have relatively potent AR inhibitory activity. Systematic fractionation of the ether soluble fraction monitored by bioassay led to isolation of two furanocoumarins, byakangelicin(I) and ter-O-methyl byakangelicin( II), were identified as potential AR inhibitors, their $IC_{50}$ values being 6.2 M and 2.8 M, respectively.

• Archives of Pharmacal Research
• /
• 제27권6호
• /
• pp.619-623
• /
• 2004

Tissue factor (TF, tissue thromboplastin) is a membrane bound glycoprotein, which acceler-ates the blood clotting, activating both the intrinsic and the extrinsic pathways to serve as a cofactor for activated factor VII (Vila). The TF-factor Vila complex (TF/VIIa) proteolytically activates factors IX and X, which leads to the generation of thrombin and fibrin clots. In order to isolate TF inhibitors, by means of a bioassay-directed chromatographic separation technique, from the leaves of Eriobotrya japonica Lindley (Rosaceae), a known sesquiterpene glycoside (2) and ferulic acid (3) were isolated as inhibitors that were evaluated using a single-clotting assay method for determining TF activity. Another sesquiterpene glycoside (1) was also isolated but was inactive in the assay system. Compound 3 was yielded by alkaline hydrolysis of compound 2. The structures of compounds 1, 2, and 3 were identified by means of spectral analysis as $3-O-{\alph}-L-rhamnopyranosyl-(1{\rightarrow}4)-a-L-rhamnopyranosyl-(1{\rightarrow}2)-[{\alph}-L-rhamnopyrano-syl-(1{\rightarrow}6)]-{\beta}-D-glucopyranosyl nerolidol$ (1), $3-O-{\alph}-L-rhamnopyranosyl-(1{\rightarrow}4)-{\alph}-L-rhamnopyr-anosyl-(1{\rightarrow}2)-[{\alph}-L-(4-trans-feruloyl)-rhamnopyranosyl-(1{\rightarrow}6)]-{\beta}-D-glucopyranosyl$ nerolidol (2) and ferulic acid (3), respectively. Compounds 2 and 3 inhibited 50% of the TF activity at con-centrations of 2 and $369{\;}\mu\textrm{m}/TF$ units, respectively.

• Natural Product Sciences
• /
• 제26권4호
• /
• pp.259-267
• /
• 2020

Snakebite is a severe medical, economic, and social problem across the world, mostly in the tropical and subtropical area. These regions of the globe have typical of the world's venomous snakes present where access to prompt treatment is limited or not available. Snake venom is a complex mixture of toxin proteins like neurotoxin and cardiotoxin, and other enzymes like phospholipase A2 (PLA2), haemorrhaging, transaminase, hyaluronidase, phosphodiesterase, acetylcholinesterase, cytolytic and necrotic toxins. Snake venom shows a wide range of biological effects like anticoagulation or platelet aggregation, hemolysis, hypotension and edema. Phospholipase A2 is the principal constituent of snake venom; it catalyzes the hydrolysis of the sn-2 position of membrane glycerophospholipids to liberate arachidonic acid, which is the precursor of eicosanoids including prostaglandins and leukotrienes. The information regarding the structure and function of the phospholipase A2 enzyme may help in treating the snakebite victims. This review article constitutes a brief description of the structure, types, mechanism occurrence, and tests of phospholipase A2 and role of components of medicinal plants used to inhibit phospholipase A2.

• Journal of Ginseng Research
• /
• 제23권4호
• /
• pp.205-210
• /
• 1999

전자수용체인 DCPIP 처리구에서 모상근의 생장은 광상태에서 대조구 보다 약 $69\%$정도 향상되었으나 7종류의 ginsenosides함량에는 영향을 미치지 않았다. 반면, 전자전달 저해제(electron transport inhibitors) 처리구에서 CCCP와 methylarnine은 광상태에서 모상근의 생장을 각각 $71%,\;22\%$ 감소시켰다. 그러나 traizine 처리구를 제외한 모든 처리구에서 7종류의 ginsenosides함량은 오히려 암 및 광상태에서 대조구보다 $45\%$ 이상 감소하였다. 항산화제 처리구에서 propylgallic acid는 광상태하에서 인삼모상근의 생장을 대조구보다 $68\%$ 증가시켰으며, ascorbic acid와 DMF처리구에서는 각각 $23\~25\%$ 정도 증가하였다. 모든 항산화제 처리구에서는 7종류의 ginsenoside 함량 변화에 영향을 미치지 않았다. 인삼모상근의 생장 및 ginsenosides생산성 향상에 효과적인 ascorbic acid와 DMF의 처리시기는 1/2MS배지에서 4주간 배양한 후 1주간 처리하였을 때 가장 양호하였다. 따라서 인삼모상근으로부터 ginsenosides생산성을 향상을 위해서는 적절한 항산화제의 개발이 요구된다.

• 한국식품영양과학회지
• /
• 제32권7호
• /
• pp.971-975
• /
• 2003

우리나라가 고령화사회에서 고령사회로, 고령사회에서 초고령사회로 도달하는 시간이 각각 22년과 10년으로 추정되며 선진국에 비해 진입속도가 빠를 것으로 보고 있다. 고령화인구에 따라 일상생활은 물론 지역 사회에서의 활동, 더 나아가서는 직업 활동을 할 수 없는 기억 장애현상인 노인성 치매가 더욱 문제시된다. 따라서 본 연구에서는 우리나라에서 정신건강 관련하여 이미 이용되고 있거나 민간에서 구두로 알려진 식품 총 100종을 선정하고, 메탄올 추출물에 대하여 prolyl endopeptidase에 대한 활성 저해율을 측정하였다. 그 결과, 40ppm 농도에서 도토리가 96.0%로 가장 높은 활성 저해율을 보였고, 산딸기가 92.0%, 호두가 73.0%로 나타났으며, 그 외의 나머지 식품들은 56.1%인 녹차를 제외하고는 모두 50% 미만의 수준이었다. 본 연구결과 PEP에 비교적 특이적으로 작용하는 저해제로서 도토리와 산딸기를 확인할 수 있었고, 현재까지 개발되고 보고된 합성 peptide인 PEP저해제와는 달리 천연식품이란 점에서, 앞으로 이 식품들이 항치매 예방 기작 구명에 유용하게 이용됨과 동시에 치매의 예방을 위한 기능성 식품으로서 이용될 수 있을 것으로 기대된다.

• 대한약학회:학술대회논문집
• /
• 대한약학회 2001년도 Proceedings of International Convention of the Pharmaceutical Society of Korea
• /
• pp.267.3-268
• /
• 2001

• 미생물학회지
• /
• 제41권4호
• /
• pp.275-280
• /
• 2005

Bacillus anthracis는 탄저병의 병원체이다. 탄저병의 독소는 Bacillus anthracis가 가진 세가지 독소로 이루어져 있다. protective antigen (PA), lethal factor (LF)그리고 edema factor (EF)로 구성되어 있다. PA는 세포수용체와 결합하여 활성화 과정을 거친 후 LF 흑은 EF를 세포질 안으로 이동시켜 주는 역할을 한다. LF는 금속이온 $(Zn^{2+})$ 의존적 단백질 가수분해 효소로써 탄저병에 감염된 동물들의 치사독소로 작용하게 된다. 따라서 LF에 대한 특성 분석 및 억제재 개발에 관한 연구는 탄저치료제 개발에 매우 중요한 과정이라 할 수 있다. 본 연구에서는 탄저독소의 치료제 개발을 위해 선행되어야 하는 LF 고처리량 활성검증방법 및 저해제 선별에 더 높은 효율을 가지기 위해 이러한 시스템 방법 등을 이용하여 세포내 검정방법의 기초 자료를 마련하고자 하였다. 이를 위하여 yeast를 숙주로 한 LF 발현 vector의 구축과, 구축한 발현 시스템을 yeast에 형질전환 하여 plasmid의 안정성 및 LF유전자의 발현을 확인하였다. 본 연구는 LF유전자의 발현을 진핵세포 내에서 처음으로 시도했으며, 세포내 검증 시스템 도입의 기초적 자료를 제공하였다. Yeast내에서의 LF의 발현은 탄저병의 저해제 선별이나 활성측정검증을 생체 내에서 용이하게 할 수 있다는 가능성을 나타냈다.